Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus

Sevcuka, Adriana, White, Kenneth and Terry, Cassandra (2022) Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus. Life (Basel, Switzerland), 12 (4). pp. 1-19. ISSN 2075-1729

Preview

Text life-12-00583.pdf - Published Version Available under License Creative Commons Attribution 4.0. Download (1MB) | Preview

Abstract / Description

Cases of Type 2 Diabetes Mellitus (T2DM) are increasing at an alarming rate due to the rise in obesity, sedentary lifestyles, glucose-rich diets and other factors. Numerous studies have increasingly illustrated the pivotal role that human islet amyloid polypeptide (hIAPP) plays in the pathology of T2DM through damage and subsequent loss of pancreatic β-cell mass. HIAPP can misfold and form amyloid fibrils which are preceded by pre-fibrillar oligomers and monomers, all of which have been linked, to a certain extent, to β-cell cytotoxicity through a range of proposed mechanisms. This review provides an up-to-date summary of recent progress in the field, highlighting factors that contribute to hIAPP misfolding and aggregation such as hIAPP protein concentration, cell stress, molecular chaperones, the immune system response and cross-seeding with other amyloidogenic proteins. Understanding the structure of hIAPP and how these factors affect amyloid formation will help us better understand how hIAPP misfolds and aggregates and, importantly, help identify potential therapeutic targets for inhibiting amyloidosis so alternate and more effective treatments for T2DM can be developed.

Item Type:	Article
Uncontrolled Keywords:	human islet amyloid polypeptide; amyloidosis; type 2 diabetes mellitus; aggregation
Subjects:	600 Technology > 610 Medicine & health
Department:	School of Human Sciences
Depositing User:	Cassandra Terry
Date Deposited:	16 May 2022 14:58
Last Modified:	27 May 2022 10:47
URI:	https://repository.londonmet.ac.uk/id/eprint/7638

Downloads

Actions (login required)

View Item